Clinical trial
S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or…
NCT00445601 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00445601 |
|---|---|
| Title | S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer |
| Official title | A Phase III Blinded Study of Immediate Post TURBT Instillation of Gemcitabine Versus Saline in Patients With Newly Diagnosed or Occasionally Recurring Grade I/II Superficial Bladder Cancer |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug, Other |
| Interventions | gemcitabine hydrochloride, placebo |
| Enrollment | 406 |
| Start date | Sep 1, 2007 |
| Primary completion | Jun 1, 2017 |
| Completion | Jun 1, 2017 |
| First posted | Mar 9, 2007 |
| Last update posted | Jan 18, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: